MA44893A1 - Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopique - Google Patents
Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopiqueInfo
- Publication number
- MA44893A1 MA44893A1 MA44893A MA44893A MA44893A1 MA 44893 A1 MA44893 A1 MA 44893A1 MA 44893 A MA44893 A MA 44893A MA 44893 A MA44893 A MA 44893A MA 44893 A1 MA44893 A1 MA 44893A1
- Authority
- MA
- Morocco
- Prior art keywords
- prevention
- treatment
- atopic dermatitis
- probiotics
- lactis
- Prior art date
Links
- 206010012438 Dermatitis atopic Diseases 0.000 title abstract 2
- 201000008937 atopic dermatitis Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000006041 probiotic Substances 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 abstract 2
- 241001608472 Bifidobacterium longum Species 0.000 abstract 2
- 244000199866 Lactobacillus casei Species 0.000 abstract 2
- 241001134770 Bifidobacterium animalis Species 0.000 abstract 1
- 235000013958 Lactobacillus casei Nutrition 0.000 abstract 1
- 229940118852 bifidobacterium animalis Drugs 0.000 abstract 1
- 229940009291 bifidobacterium longum Drugs 0.000 abstract 1
- 229940017800 lactobacillus casei Drugs 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Non-Alcoholic Beverages (AREA)
- Dairy Products (AREA)
- Confectionery (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La présente invention concerne l'utilisation d'une composition probiotique comprenant bifidobacterium animalis subsp. Lactis (b. Lactis), bifidobacterium longum et lactobacillus casei, en particulier les souches b. Lactis cect 8145, b. Longum cect 7347 et/ou l. Casei cect 9104, dans le traitement et/ou la prévention de la dermatite atopique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16382342.0A EP3272396A1 (fr) | 2016-07-18 | 2016-07-18 | Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopique |
PCT/EP2017/068131 WO2018015388A1 (fr) | 2016-07-18 | 2017-07-18 | Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopique |
Publications (2)
Publication Number | Publication Date |
---|---|
MA44893A1 true MA44893A1 (fr) | 2019-05-31 |
MA44893B1 MA44893B1 (fr) | 2021-06-30 |
Family
ID=56920674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA44893A MA44893B1 (fr) | 2016-07-18 | 2017-07-18 | Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopique |
Country Status (28)
Country | Link |
---|---|
US (2) | US20190282636A1 (fr) |
EP (2) | EP3272396A1 (fr) |
JP (1) | JP6998364B2 (fr) |
KR (1) | KR102390806B1 (fr) |
CN (1) | CN110214014A (fr) |
AR (1) | AR109085A1 (fr) |
AU (1) | AU2017299137B2 (fr) |
BR (1) | BR112019001116A2 (fr) |
CA (1) | CA3031002A1 (fr) |
DK (1) | DK3484585T3 (fr) |
EA (1) | EA201990086A1 (fr) |
ES (1) | ES2863398T3 (fr) |
HR (1) | HRP20210995T1 (fr) |
HU (1) | HUE055264T2 (fr) |
IL (1) | IL264282B1 (fr) |
MA (1) | MA44893B1 (fr) |
MX (1) | MX2019000821A (fr) |
MY (1) | MY194858A (fr) |
PE (1) | PE20190417A1 (fr) |
PH (1) | PH12019500123A1 (fr) |
PL (1) | PL3484585T3 (fr) |
PT (1) | PT3484585T (fr) |
RS (1) | RS62079B1 (fr) |
RU (1) | RU2757453C2 (fr) |
SI (1) | SI3484585T1 (fr) |
UA (1) | UA126664C2 (fr) |
WO (1) | WO2018015388A1 (fr) |
ZA (1) | ZA201900869B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109652349B (zh) * | 2019-02-25 | 2021-03-02 | 江南大学 | 一株能够缓解特应性皮炎的长双歧杆菌及其应用 |
KR102136346B1 (ko) * | 2019-12-23 | 2020-07-22 | 주식회사 락토메이슨 | 한국인 영유아 유래 신규한 비피도박테리움 애니멀리스 락티스 lm1017을 유효성분으로 포함하는, 아토피 피부염의 예방 및 치료용 조성물 |
EP3851115A1 (fr) | 2020-01-15 | 2021-07-21 | Biopolis, S.L. | Composition probiotique pour son utilisation en tant qu'antioxydant |
CN111296842B (zh) * | 2020-02-14 | 2021-01-05 | 赵一鸣 | 一种具有抗敏作用的益生菌组合物 |
CN111528479A (zh) * | 2020-05-15 | 2020-08-14 | 深圳爱米基因科技有限责任公司 | 一种缓解特应性皮炎功能的益生菌和益生元组合物及应用 |
EP3915537A1 (fr) * | 2020-05-28 | 2021-12-01 | DuPont Nutrition Biosciences ApS | Bifidobactéries pour la prévention, la réduction ou le traitement du vieillissement de la peau |
EP3973971A1 (fr) * | 2020-09-28 | 2022-03-30 | Medice Arzneimittel Pütter GmbH & Co. KG | Compositions pharmaceutique comprenant un probiotique |
CN113430133B (zh) * | 2021-06-24 | 2023-06-23 | 微康益生菌(苏州)股份有限公司 | 一种能够缓解溃疡性结肠炎的复合益生菌、制备方法及其应用 |
WO2023111270A1 (fr) * | 2021-12-16 | 2023-06-22 | Biopolis, S. L. | Utilisation de postbiotiques dans le traitement et/ou la prévention de troubles de l'anxiété |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004250337A (ja) * | 2003-02-18 | 2004-09-09 | Sunstar Inc | アレルギー疾患改善用製剤 |
JP5112069B2 (ja) | 2004-10-04 | 2013-01-09 | ロレアル | 敏感肌のための化粧品及び/または皮膚科組成物 |
CN101165162A (zh) * | 2007-09-30 | 2008-04-23 | 苏国权 | 一种益生菌活性制剂 |
ES2343499B1 (es) * | 2007-12-24 | 2011-06-10 | Consejo Superior De Investigaciones Cientificas | Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten. |
MX338680B (es) * | 2009-05-11 | 2016-04-27 | Nestec Sa | Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes. |
EP2251020A1 (fr) * | 2009-05-11 | 2010-11-17 | Nestec S.A. | Traitement haute température de courte durée qui génère des préparations microbiennes avec des profils anti-inflammatoires |
EP2228067B1 (fr) * | 2010-02-22 | 2013-12-11 | LR Health & Beauty Systems GmbH | Composition probiotique et son utilisation |
ES2389547B1 (es) * | 2010-12-07 | 2013-08-08 | Consejo Superior De Investigaciones Científicas (Csic) | Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas. |
KR20130049554A (ko) * | 2011-11-04 | 2013-05-14 | 주식회사 쎌바이오텍 | 아토피 예방 또는 치료용 조성물 |
ES2526986B1 (es) * | 2013-07-18 | 2015-11-02 | Biopolis, S.L. | Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas |
CN104605277A (zh) * | 2013-11-05 | 2015-05-13 | 熊涛 | 一种功能性益生菌发酵果蔬粉的制备方法 |
KR101545551B1 (ko) * | 2013-12-12 | 2015-08-19 | 주식회사한국야쿠르트 | 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물 |
CN103705543A (zh) * | 2013-12-25 | 2014-04-09 | 广州华农大实验兽药有限公司 | 一种动物用粪源复方益生菌可溶性粉及其制备方法 |
KR101724601B1 (ko) * | 2014-11-04 | 2017-04-10 | 주식회사 쎌바이오텍 | 아토피 예방 또는 치료용 조성물 |
-
2016
- 2016-07-18 EP EP16382342.0A patent/EP3272396A1/fr not_active Withdrawn
-
2017
- 2017-07-18 CN CN201780057072.1A patent/CN110214014A/zh active Pending
- 2017-07-18 EP EP17737847.8A patent/EP3484585B1/fr active Active
- 2017-07-18 CA CA3031002A patent/CA3031002A1/fr active Pending
- 2017-07-18 PE PE2019000223A patent/PE20190417A1/es unknown
- 2017-07-18 PL PL17737847T patent/PL3484585T3/pl unknown
- 2017-07-18 RS RS20210797A patent/RS62079B1/sr unknown
- 2017-07-18 AR ARP170101998A patent/AR109085A1/es unknown
- 2017-07-18 IL IL264282A patent/IL264282B1/en unknown
- 2017-07-18 DK DK17737847.8T patent/DK3484585T3/da active
- 2017-07-18 US US16/318,684 patent/US20190282636A1/en active Pending
- 2017-07-18 HU HUE17737847A patent/HUE055264T2/hu unknown
- 2017-07-18 WO PCT/EP2017/068131 patent/WO2018015388A1/fr unknown
- 2017-07-18 MX MX2019000821A patent/MX2019000821A/es unknown
- 2017-07-18 BR BR112019001116-1A patent/BR112019001116A2/pt unknown
- 2017-07-18 SI SI201730813T patent/SI3484585T1/sl unknown
- 2017-07-18 ES ES17737847T patent/ES2863398T3/es active Active
- 2017-07-18 AU AU2017299137A patent/AU2017299137B2/en active Active
- 2017-07-18 MA MA44893A patent/MA44893B1/fr unknown
- 2017-07-18 RU RU2019104462A patent/RU2757453C2/ru active
- 2017-07-18 EA EA201990086A patent/EA201990086A1/ru unknown
- 2017-07-18 MY MYPI2019000115A patent/MY194858A/en unknown
- 2017-07-18 UA UAA201901377A patent/UA126664C2/uk unknown
- 2017-07-18 PT PT177378478T patent/PT3484585T/pt unknown
- 2017-07-18 JP JP2019503412A patent/JP6998364B2/ja active Active
- 2017-07-18 KR KR1020197004714A patent/KR102390806B1/ko active IP Right Grant
-
2019
- 2019-01-17 PH PH12019500123A patent/PH12019500123A1/en unknown
- 2019-02-11 ZA ZA2019/00869A patent/ZA201900869B/en unknown
-
2021
- 2021-06-23 HR HRP20210995TT patent/HRP20210995T1/hr unknown
-
2022
- 2022-08-15 US US17/888,317 patent/US20230048705A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA44893A1 (fr) | Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopique | |
MA43488B1 (fr) | Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis | |
NZ777234A (en) | Compositions comprising bacterial strains | |
CO2018010954A2 (es) | Nuevo uso médico de probioticos | |
MX2011012069A (es) | Micro-organismos no-replicantes y su efecto inmuno estimulador. | |
MX2022003373A (es) | Composiciones a base de cepas bacterianas y su uso como antiinflamatorios. | |
PH12018550110A1 (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
MX2022003372A (es) | Cepas bacterianas, sus composiciones y su uso para el tratamiento de trastornos gastrointestinales. | |
IT201600091033A1 (it) | Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti. | |
MX2017007654A (es) | Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas. | |
PH12017502042A1 (en) | Dietary supplement | |
MX2016014991A (es) | Composiciones que contienen acido borico y una mezcla de lactobacilos. | |
HK1198326A1 (zh) | 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種 | |
HRP20130487A2 (hr) | Formulacija probiotika s apigeninom i ekstraktom paprene metvice | |
WO2015121458A3 (fr) | Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149 | |
AU2019263623A8 (en) | Probiotic Bifidobacterium breve strain and compositions comprising said strain | |
MX2017008700A (es) | Empleo de probioticos en el incremento de la fertilidad masculina. | |
UA127306U (uk) | Комплексний пробіотичний препарат | |
PL397178A1 (pl) | Kompozycja probiotyczna | |
UA120331U (uk) | Пробіотик "болмол" | |
UA89242U (uk) | Склад йогурту | |
PL406051A1 (pl) | Zastosowanie kompozycji probiotycznej | |
RS54225B1 (en) | Indigenous LACTOBACILLUS strains and their use as probiotics | |
UA105131U (uk) | Склад йогурту | |
RU2012102853A (ru) | Штамм lactococcus casei вкпм в-8730, используемый для приготовления кисло-молочных продуктов и пробиотических препаратов |